Elizabeth Rozek - 04 Nov 2025 Form 4 Insider Report for Sagimet Biosciences Inc. (SGMT)

Role: Chief Legal & Admin. Officer
Signature: /s/ Elizabeth Rozek
Issuer symbol: SGMT
Transactions as of: 04 Nov 2025
Net transactions value: $0
Form type: 4
Filing time: 06 Nov 2025, 16:43:41 UTC
Previous filing: 23 Jul 2025
Next filing: 12 Feb 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Rozek Elizabeth	Chief Legal & Admin. Officer	SAGIMET BIOSCIENCES INC., 155 BOVET ROAD, SUITE 303, SAN MATEO	/s/ Elizabeth Rozek	06 Nov 2025	0001975022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	SGMT	Series A Common Stock	Award	$0	+9,855	+5.4%	$0.000000	193,581	04 Nov 2025	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	SGMT	Stock Option (Right to Buy)	Award	$0	+13,367		$0.000000	13,367	04 Nov 2025	Series A Common Stock	13,367	$7.61	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents restricted stock units ("RSUs") granted in connection with the Reporting Person's promotion within the Company. Each RSU represents a contingent right to receive one share of the Issuer's Series A Common Stock upon vesting and settlement. The RSUs shall vest over four equal annual installments following November 4, 2025, subject to the Reporting Person's continued service on each such vesting date.
F2	This option was granted in connection with the Reporting Person's promotion within the Company. The shares underlying this option shall vest and become exercisable over forty-eight equal monthly installments following November 4, 2025, subject to the Reporting Person's continued service on each such vesting date.

Content

Represents restricted stock units ("RSUs") granted in connection with the Reporting Person's promotion within the Company. Each RSU represents a contingent right to receive one share of the Issuer's Series A Common Stock upon vesting and settlement. The RSUs shall vest over four equal annual installments following November 4, 2025, subject to the Reporting Person's continued service on each such vesting date.

This option was granted in connection with the Reporting Person's promotion within the Company. The shares underlying this option shall vest and become exercisable over forty-eight equal monthly installments following November 4, 2025, subject to the Reporting Person's continued service on each such vesting date.